A new analysis presented at HYP 2025 found that combining certain antidepressants (SSRIs, SNRIs, bupropion, duloxetine) with CYP2D6-metabolized beta blockers significantly increases drug exposure, lowers systolic blood pressure by up to 20%, and raises bradycardia risk by 25%.
Study Details
Depression and hypertension often coexist, making the concurrent …



